The best indicator for Microchip Technology (MCHP)
We backtested 20 indicators across daily, weekly and hourly charts on real Microchip Technology (MCHP) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Bollinger Mean-Reversion
On the daily chart, this is the strongest risk-adjusted edge we found for Microchip Technology (MCHP) over ~33.2 years — trailing buy-and-hold by 3.9% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Bollinger Mean-Reversion ✓ | Daily | 16.7% | 0.71 | -41.4% | 69.7% | 155 | -3.9% |
| 2 | Williams %R ✓ | Daily | 15.2% | 0.59 | -65.2% | 73.7% | 228 | -5.4% |
| 3 | Stochastic ✓ | Daily | 13.9% | 0.57 | -57.9% | 74.1% | 166 | -6.7% |
| 4 | CCI ✓ | Daily | 13.1% | 0.54 | -58.7% | 75.7% | 173 | -7.5% |
| 5 | Money Flow Index ✓ | Daily | 10.9% | 0.5 | -62.4% | 76.9% | 26 | -9.7% |
| 6 | Williams %R ✓ | Weekly | 11.0% | 0.5 | -55.3% | 72.3% | 47 | -9.5% |
| 7 | Holy Grail Confluence ✓ | Daily | 10.3% | 0.49 | -57.0% | 83.0% | 47 | -10.3% |
| 8 | WaveTrend (8/6/4) ✓ | Daily | 9.0% | 0.42 | -61.9% | 69.4% | 124 | -11.6% |
| 9 | CCI ✓ | Weekly | 7.7% | 0.42 | -55.4% | 84.4% | 32 | -12.8% |
| 10 | WaveTrend (8/6/4) ✓ | Weekly | 8.0% | 0.42 | -58.9% | 77.8% | 27 | -12.5% |
| 11 | EMA 20/50 Cross ✓ | Daily | 6.2% | 0.35 | -77.4% | 40.0% | 75 | -14.4% |
| 12 | Stochastic ✓ | Weekly | 5.9% | 0.35 | -54.4% | 72.4% | 29 | -14.6% |
| 13 | Donchian Midline ✓ | Weekly | 6.3% | 0.35 | -72.0% | 44.7% | 94 | -14.2% |
| 14 | SMA 50/200 Cross ✓ | Daily | 6.0% | 0.34 | -65.8% | 46.2% | 26 | -14.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Microchip Technology (MCHP), Bollinger Mean-Reversion on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.